Welcome to our dedicated page for Aeluma SEC filings (Ticker: ALMU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aeluma's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aeluma's regulatory disclosures and financial reporting.
Aeluma, Inc. director and Chief Executive Officer Jonathan Klamkin reported several transactions in common stock on August 3, 2026. He recorded bona fide gifts totaling 40,000 shares, including a 20,000-share disposition of shares held indirectly through a family trust and a 20,000-share acquisition into direct ownership. He also sold 20,000 shares in open-market or private transactions under a Rule 10b5-1 trading plan adopted on December 3, 2025, consisting of 4,190 shares at a weighted-average price of $16.2918 per share (range $15.62–$16.61) and 15,810 shares at $16.8487 per share (range $16.62–$17.53).
Aeluma, Inc. entered a CHIPS and Science Act Letter of Intent with the U.S. Department of Commerce’s CHIPS Research & Development Office for up to $30 million in proposed funding. The LOI supports R&D and commercialization of Aeluma’s scalable non-InP photonics manufacturing platform for AI and advanced computing applications.
The potential award is subject to further due diligence, required U.S. government approvals, and execution of definitive award documents. The LOI contemplates a portion of funds paid up front and the balance on a milestone-based structure, with Aeluma issuing unregistered equity securities to Commerce with an aggregate value equal to any final award.
BlackRock, Inc. reported a passive ownership stake in AELUMA INC common stock. BlackRock beneficially owns 963,791 shares of Aeluma common stock, representing 5.3% of the outstanding class as of the reporting date.
BlackRock has sole voting power951,382 shares and sole dispositive power963,791 shares, with no shared voting or dispositive power. Various underlying clients and investors have rights to dividends or sale proceeds, but no single underlying holder has more than 5% of Aeluma’s outstanding common shares.
Aeluma, Inc. reports that CEO Jonathan Klamkin executed multiple common stock transactions on July 1, 2026. One bona fide gift disposition moved 20,000 shares held indirectly by a family trust, and a separate gift transaction recorded acquisition of 20,000 shares into his direct ownership.
He then sold 19,900 shares at a weighted average price of $21.081 per share in transactions priced between $20.54 and $21.52, plus an additional 100 shares at $21.56, in open market or private transactions. After these trades, he holds 2,403 shares of Aeluma common stock directly. Footnotes explain that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2025.
Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing proposed resale of 40,000 shares of Common Stock identified as Founders Shares with an original issuance date of 10/27/2020. The excerpt lists two 10b5-1 sales by Jonathan Klamkin: 20,000 shares sold on 06/01/2026 for $500,662 and 20,000 shares sold on 05/01/2026 for $499,242.
Aeluma, Inc. Chief Executive Officer Jonathan Klamkin reported multiple insider transactions in the company’s common stock. On June 1, 2026, he sold a total of 20,000 shares in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025.
The sales were executed in several tranches at weighted average prices of $22.19, $23.32, $24.39, $25.12 and $26.25 per share. He also made bona fide gifts totaling 40,000 shares, including 20,000 shares from his direct holdings and 20,000 shares from an indirect position held by a family trust.
Following these transactions, Klamkin directly holds 22,403 shares of Aeluma common stock and indirectly holds 1,366,995 shares through a family trust.
Aeluma, Inc. director Steven Denbaars reported open-market sales of 25,000 shares of Common Stock. The sales occurred on May 19–20, 2026 at weighted average prices ranging from about $19.56 to $21.30 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025. Following these transactions, he directly holds 370,209 shares of Aeluma common stock.
ALMU reported insider sales via Form 144. The filing shows Steven DenBaars reported sales of 12,500 shares on 02/25/2026 and 12,500 shares on 02/26/2026. The filing lists 18,305,335 shares outstanding as of 05/19/2026.
The transactions are reported on a Form 144 submission and identify the securities as Common Stock. The reported broker/dealer appears as Merrill Lynch.
Aeluma, Inc. furnished an updated investor presentation outlining its semiconductor photonics strategy and business position. The company highlights its Indium Gallium Arsenide (InGaAs) and large‑diameter wafer technology aimed at shortwave infrared sensing, AI infrastructure, datacom, defense, and quantum markets.
The deck notes recurring R&D revenue of $4 FY25, cash of about $37 as of 3/31/26, around 36 issued and pending patents, and more than 20 customer engagements, including sampling, NRE work and initial sales. Aeluma reports a 27-person team, capital‑light manufacturing that relies on partners, ISO 9001:2015 certification, and about 12k sq. ft. of facilities in Goleta, California with materials production and test capabilities.
The presentation frames large market opportunities in mobile and consumer SWIR sensors and AI data-center optical interconnects, citing substantial hyperscaler data-center capital spending and an industry shortage of indium phosphide substrates and fab capacity.
Aeluma, Inc. reports an amended Schedule 13G/A showing reduced ownership. Mark N. Tompkins now reports 885,000 shares of Common Stock, representing 4.83% of the class based on May 8, 2026 outstanding shares. The amendment states this is an exit filing because the reporting person ceased to be a beneficial owner of more than 5%. The filing notes the reported percentage is calculated from 18,305,335 shares outstanding as of May 8, 2026 and that the reported amount includes the reporting person’s beneficial ownership as of March 31, 2026.